bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Mouth Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calderwood-Mays, M; Fox, LE; Helfand, SC; King, RR; Kurzman, ID; Levine, PB; MacEwen, EG; Perez-Soler, R; Rosenthal, RC; Vail, DM | 1 |
1 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Mouth Neoplasms
Article | Year |
---|---|
Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Infusions, Intravenous; Male; Mouth Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Proportional Hazards Models; Prospective Studies; Radiography, Thoracic; Surveys and Questionnaires | 2000 |